Literature DB >> 16437673

Synergistic action of famotidine and chlorpheniramine on acetic acid-induced chronic gastric ulcer in rats.

Zhen Qin1, Chao Chen.   

Abstract

AIM: To assess the synergistic action of famotidine (FMD) and chlorpheniramine (CPA) on acetic acid-induced chronic gastric ulcer in rats.
METHODS: Chronic gastric lesions were induced in male Sprague-Dawley (SD) rats by serosal application of the acetic acid. Forty SD rats were randomly divided into blank group (n = 8), control group (n = 8), FMD group (n = 8), CPA group (n = 8), and FMD+CPA group (n = 8). Each group was given intraperitoneally (i.p.) 0.5 mL/100 g distilled water, 9 g/L NaCl saline, 4 mg/kg FMD, 10 mg/kg CPA, 4 mg/kg FMD+10 mg/kg CPA, respectively, daily for 10 d. On d 10, ulcer area was determined by planimetry. The level of myeloperoxidase (MPO) in the liver homogenization was determined by biochemical methods and the plasma levels of 6-ketoprostaglandin F1 alpha (6-keto-PGF(1a)) and IL-8 were determined by radioimmunoassay.
RESULTS: The synergistic effects of FMD+CPA group on the lesion, IL-8, 6-keto-PGF(1a) and MPO were confirmed. The effect of FMD+CPA group was significantly different as compared to the control and FMD groups. The lesion (mm(2)) was reduced from 40.18+/-2.6 in control group to 6.83+/-2.97 in PMD+CPA group, P<0.01, and from 32.9+/-3.27 in FMD group to 6.83+/-2.97 in PMD+CPA group, P<0.01. The plasma levels of IL-8 decreased from 0.69+/-0.11 ng/L in control group to 0.4+/-0.04 ng/L in PMD+CPA group, P<0.01, and from 0.51+/-0.08 ng/L in FMD group to 0.4+/-0.04 ng/L in PMD+CPA group, P<0.05. The level of 6-keto-PGF(1a) increased from 7.55+/-1.65 ng/L in control group to 16.62+/-0.97 ng/L in PMD+CPA group, P<0.01, and from 13.15+/-1.48 ng/L in FMD group to 16.62+/-0.97 ng/L in PMD+CPA group, P<0.05. The levels of MPO in the liver homogenate decreased from 9.12+/-2.05 u/L in control group to 4.33+/-0.95 u/L in PMD+CPA group, P<0.01, and from 8.3+/-1.29 u/L in FMD group to 4.33+/-0.95 u/L, P<0.01.
CONCLUSION: The synergistic action of FMD and CPA on acetic acid-induced chronic gastric ulcer in rats decreases the incidence of ulcer and also enhances the healing of ulcer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16437673      PMCID: PMC4725076          DOI: 10.3748/wjg.v11.i45.7203

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  26 in total

1.  Olopatadine inhibits TNFalpha release from human conjunctival mast cells.

Authors:  E B Cook; J L Stahl; N P Barney; F M Graziano
Journal:  Ann Allergy Asthma Immunol       Date:  2000-05       Impact factor: 6.347

2.  Regional variation in purinergic and adrenergic responses in isolated vas deferens of rat, rabbit and guinea-pig.

Authors:  P Sneddon; M Machaly
Journal:  J Auton Pharmacol       Date:  1992-12

3.  Cetirizine counter-regulates interleukin-8 release from human epithelial cells (A549)

Authors:  R Arnold; J Rihoux; W König
Journal:  Clin Exp Allergy       Date:  1999-12       Impact factor: 5.018

4.  A new method for the production of chronic gastric ulcer in rats and the effect of several drugs on its healing.

Authors:  K Takagi; S Okabe; R Saziki
Journal:  Jpn J Pharmacol       Date:  1969-09

Review 5.  Is smoking still important in the pathogenesis of peptic ulcer disease?

Authors:  G L Eastwood
Journal:  J Clin Gastroenterol       Date:  1997       Impact factor: 3.062

6.  Effect of a histamine H1 receptor antagonist on gastric endocrine cell proliferation induced by chronic acid suppression in rats.

Authors:  G Chen; H Kashiwagi; N Omura; T Aoki
Journal:  J Gastroenterol       Date:  2000       Impact factor: 7.527

7.  Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro.

Authors:  S E Crowe; L Alvarez; M Dytoc; R H Hunt; M Muller; P Sherman; J Patel; Y Jin; P B Ernst
Journal:  Gastroenterology       Date:  1995-01       Impact factor: 22.682

8.  Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury.

Authors:  A Robert; J E Nezamis; C Lancaster; A J Hanchar
Journal:  Gastroenterology       Date:  1979-09       Impact factor: 22.682

Review 9.  Eicosanoids and the gastrointestinal tract.

Authors:  C E Eberhart; R N Dubois
Journal:  Gastroenterology       Date:  1995-07       Impact factor: 22.682

10.  Mechanisms involved in Helicobacter pylori-induced inflammation.

Authors:  N Yoshida; D N Granger; D J Evans; D G Evans; D Y Graham; D C Anderson; R E Wolf; P R Kvietys
Journal:  Gastroenterology       Date:  1993-11       Impact factor: 22.682

View more
  3 in total

1.  Protective effects of ginger and marshmallow extracts on indomethacin-induced peptic ulcer in rats.

Authors:  Sameh S Zaghlool; Basim A Shehata; Ali A Abo-Seif; Hekma A Abd El-Latif
Journal:  J Nat Sci Biol Med       Date:  2015 Jul-Dec

2.  Formulation and Evaluation of Silymarin-Loaded Chitosan-Montmorilloite Microbeads for the Potential Treatment of Gastric Ulcers.

Authors:  Ameya Sharma; Vivek Puri; Vandita Kakkar; Inderbir Singh
Journal:  J Funct Biomater       Date:  2018-09-10

3.  Metabolites profiling and pharmacokinetics of troxipide and its pharmacodynamics in rats with gastric ulcer.

Authors:  Hongbin Guo; Baohua Chen; Zihan Yan; Jian Gao; Jiamei Tang; Chengyan Zhou
Journal:  Sci Rep       Date:  2020-08-12       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.